Kobayashi, S.; Ikuno, Y.; Yamada, M.; Yamaguchi, A.; Takahashi, T.; Arakawa, A.; Fujimoto, N.
Targeting the IL-23p19/Th17 Axis with Guselkumab in Systemic Sclerosis: A Domain-Based Review of All Four Published Cases. Sclerosis 2026, 4, 13.
https://doi.org/10.3390/sclerosis4020013
AMA Style
Kobayashi S, Ikuno Y, Yamada M, Yamaguchi A, Takahashi T, Arakawa A, Fujimoto N.
Targeting the IL-23p19/Th17 Axis with Guselkumab in Systemic Sclerosis: A Domain-Based Review of All Four Published Cases. Sclerosis. 2026; 4(2):13.
https://doi.org/10.3390/sclerosis4020013
Chicago/Turabian Style
Kobayashi, Souta, Yasuaki Ikuno, Masahiro Yamada, Akihiko Yamaguchi, Toshifumi Takahashi, Akiko Arakawa, and Noriki Fujimoto.
2026. "Targeting the IL-23p19/Th17 Axis with Guselkumab in Systemic Sclerosis: A Domain-Based Review of All Four Published Cases" Sclerosis 4, no. 2: 13.
https://doi.org/10.3390/sclerosis4020013
APA Style
Kobayashi, S., Ikuno, Y., Yamada, M., Yamaguchi, A., Takahashi, T., Arakawa, A., & Fujimoto, N.
(2026). Targeting the IL-23p19/Th17 Axis with Guselkumab in Systemic Sclerosis: A Domain-Based Review of All Four Published Cases. Sclerosis, 4(2), 13.
https://doi.org/10.3390/sclerosis4020013
